Fabiana Marzabal has over 15 years of experience in the pharmaceutical industry supporting pre- and commercial excellence and business insights in rare disease and oncology. Currently serving as the Senior Director of Forecasting, Analytics, and Insights at Viridian Therapeutics, Fabiana is a strategic leader known for her expertise in driving business growth and maximizing market potential.
With a strong background in real-world data, predictive analytics and market research, Fabiana excels in developing and implementing forecasting models to support decision-making processes within the organization. Her keen analytical skills and deep understanding of the orphan drug and rare disease landscape make her a valuable asset in identifying market trends and opportunities.
Passionate about improving patient experience and outcomes, Fabiana is committed to advancing innovative solutions that address unmet medical needs in rare diseases. Her collaborative approach, combined with strong communication and cross-functional leadership, has been instrumental in delivering successful, data-driven outcomes that make a meaningful difference in the industry
Patient identification in rare diseases is critical to drug development, commercialization and optimizing patient care and outcomes. Patient identification often hits roadblocks after exhausting the initial wave of diagnosed and engaged individuals, leaving many potential patients underserved. To truly maximize the impact of innovative treatments and the power of integrated care, it’s critical to understand how patients navigate the complexities of the healthcare system and identify gaps in care. In this session, we’ll explore the unique challenges of patient identification and management in rare diseases, while sharing practical, actionable strategies to drive better outcomes. Join us for an engaging and interactive discussion!